MDA-7

[mjhealthtips]

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models (full – 2008)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597252/

Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full – 2012)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/

Cannabinoid Receptor Stimulator Reverses Symptoms of Alzheimer's Disease in Animal Model (news – 2012) http://www.biotechdaily.com/?option=...emid=294742494

Researchers investigating potential drug for treatement of Alzheimer's disease (news – 2012) http://medicalxpress.com/news/2012-0...r-disease.html

Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/22795792

In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7 (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23192786

Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24361916